JP2000511888A5 - - Google Patents

Download PDF

Info

Publication number
JP2000511888A5
JP2000511888A5 JP1997540229A JP54022997A JP2000511888A5 JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5 JP 1997540229 A JP1997540229 A JP 1997540229A JP 54022997 A JP54022997 A JP 54022997A JP 2000511888 A5 JP2000511888 A5 JP 2000511888A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997540229A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000511888A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/007874 external-priority patent/WO1997041863A1/en
Publication of JP2000511888A publication Critical patent/JP2000511888A/ja
Publication of JP2000511888A5 publication Critical patent/JP2000511888A5/ja
Ceased legal-status Critical Current

Links

JP09540229A 1996-05-09 1997-05-08 混合キメリズム及び寛容 Ceased JP2000511888A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1709996P 1996-05-09 1996-05-09
US60/017,099 1996-05-09
PCT/US1997/007874 WO1997041863A1 (en) 1996-05-09 1997-05-08 Mixed chimerism and tolerance

Publications (2)

Publication Number Publication Date
JP2000511888A JP2000511888A (ja) 2000-09-12
JP2000511888A5 true JP2000511888A5 (enExample) 2005-01-13

Family

ID=21780711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09540229A Ceased JP2000511888A (ja) 1996-05-09 1997-05-08 混合キメリズム及び寛容

Country Status (9)

Country Link
US (4) US6006752A (enExample)
EP (1) EP0918524A4 (enExample)
JP (1) JP2000511888A (enExample)
AT (1) ATE245990T1 (enExample)
AU (1) AU734665B2 (enExample)
CA (1) CA2253597A1 (enExample)
DE (1) DE69723888T2 (enExample)
ES (1) ES2201977T3 (enExample)
WO (1) WO1997041863A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5871728A (en) 1995-03-31 1999-02-16 University Of Pittsburgh Method of regulating dendritic cell maturation
ES2201977T3 (es) * 1996-05-09 2004-04-01 The General Hospital Corporation Quimerismo mixto y tolerancia.
ATE439137T1 (de) * 1997-11-14 2009-08-15 Gen Hospital Corp Behandlung von hämatologischen störungen
AU748443B2 (en) 1998-02-04 2002-06-06 General Hospital Corporation, The Costimulatory blockade and mixed chimerism in transplantation
DE69929681T2 (de) * 1998-03-18 2006-10-26 Osiris Therapeutics, Inc. Mesenchymale stammzellen für die prävention und behandlung von immunantworten bei transplantationen
WO2000011147A1 (en) 1998-08-20 2000-03-02 The General Hospital Corporation Inbred mhc-homozygous miniature swine and uses thereof
AU2980900A (en) 1999-02-04 2000-08-25 General Hospital Corporation, The Methods for human allografting
WO2000054786A1 (en) * 1999-03-15 2000-09-21 Modex Therapeutiques, S.A. Methods and compositions for tolerizing hosts for long term survival of tissue transplants
US6750023B2 (en) * 1999-09-02 2004-06-15 Corning Incorporated Porous inorganic substrate for high-density arrays
US6866843B2 (en) * 1999-12-06 2005-03-15 Viacell, Inc. Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
EP1250594A4 (en) * 2000-01-19 2003-05-07 Biotransplant Inc PORC UNABLE TO TRANSMIT PORCINE ENDOGENEOUS RETROVIRUS, AND USES THEREOF
CA2427996A1 (en) * 2000-11-22 2002-06-06 Geron Corporation Tolerizing allografts of pluripotent stem cells
US20030044398A1 (en) * 2001-03-20 2003-03-06 Robl James M. Methods for producing antibodies in mammals
WO2002074938A1 (en) * 2001-03-20 2002-09-26 Trustees Of Amherst College Methods for producing antibodies in mammals
US20020152490A1 (en) * 2001-04-12 2002-10-17 Philip Lake Tolerance-inducing thy-marrow composite tissue construct and organ
US20030031652A1 (en) * 2001-04-16 2003-02-13 Bernhard Hering Systems and methods for inducing mixed chimerism
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
US20050058641A1 (en) * 2002-05-22 2005-03-17 Siemionow Maria Z. Tolerance induction and maintenance in hematopoietic stem cell allografts
AU2003228768B2 (en) * 2002-05-22 2009-02-05 The Cleveland Clinic Foundation Induction and maintenance of tolerance to composite tissue allografts
US20050112122A1 (en) * 2003-09-02 2005-05-26 Greiner Dale L. Generation of hematopoietic chimerism and induction of central tolerance
US20050266001A1 (en) * 2004-04-02 2005-12-01 Hadley Gregg A Therapeutic blockade of CD103 interactions to prevent clinical renal allograft rejection
US20060148080A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Methods for supporting and producing human cells and tissues in non-human mammal hosts
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues
WO2007033221A2 (en) * 2005-09-13 2007-03-22 The General Hospital Corporation Methods and compositions for inhibition of immune responses
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2013163176A1 (en) 2012-04-23 2013-10-31 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
EP2961431A4 (en) 2013-02-26 2016-01-20 Univ Leland Stanford Junior Combined organ and hematopoietic cells for transplantation tolerance of grafts
MX375502B (es) 2013-04-03 2025-03-04 N Fold Llc Composiciones de nanoparticulas novedosas.
GB201413240D0 (en) * 2014-07-25 2014-09-10 Hansa Medical Ab Method
EP3612023A4 (en) 2017-04-20 2021-05-12 Egenesis, Inc. Methods for generating genetically modified animals
US11273179B2 (en) 2018-03-12 2022-03-15 Medeor Therapeutics, Inc. Methods for treating non-cancerous disorders using hematopoietic cells
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US11435350B2 (en) 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors
US11813376B2 (en) 2018-09-18 2023-11-14 Medeor Therapeutics, Inc. Cellular compositions derived from deceased donors to promote graft tolerance and manufacture and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU679437B2 (en) * 1992-01-08 1997-07-03 General Hospital Corporation, The Induced tolerance to xenografts
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
US5658564A (en) * 1992-02-19 1997-08-19 The General Hospital Corporation Xenograft thymus
US5597563A (en) * 1992-09-04 1997-01-28 Beschorner; William E. Method induction of antigen-specific immune tolerance
IL107483A0 (en) * 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
ES2201977T3 (es) * 1996-05-09 2004-04-01 The General Hospital Corporation Quimerismo mixto y tolerancia.
AU748443B2 (en) * 1998-02-04 2002-06-06 General Hospital Corporation, The Costimulatory blockade and mixed chimerism in transplantation

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000505452A5 (enExample)
JP2000501324A5 (enExample)
JP2000502472A5 (enExample)
JP2000501338A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2000515570A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000511888A5 (enExample)
JP2000514140A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000514419A5 (enExample)
JP2000502714A5 (enExample)